Showing 1 - 1 results of 1 for search 'Kenichiro Nishida', query time: 0.01s Refine Results
  1. 1
    Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes

    Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporte... by Daisuke Yabe, Yutaka Seino, Kosuke Shiki, Keiko Suzaki, Thomas Meinicke, Yutaro Kotobuki, Kenichiro Nishida, Douglas Clark, Atsutaka Yasui

    Published 2021-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: